Discovery of new tranylcypromine derivatives as highly potent LSD1 inhibitors.
Gastric cancer
Histone demethylase
LSD1 inhibitor
Tranylcypromine
Journal
Bioorganic & medicinal chemistry letters
ISSN: 1464-3405
Titre abrégé: Bioorg Med Chem Lett
Pays: England
ID NLM: 9107377
Informations de publication
Date de publication:
01 06 2021
01 06 2021
Historique:
received:
22
12
2020
revised:
14
03
2021
accepted:
19
03
2021
pubmed:
30
3
2021
medline:
18
9
2021
entrez:
29
3
2021
Statut:
ppublish
Résumé
Tranylcypromine (TCP)-based structural modifications lead to the discovery of new LSD1 inhibitors, of which compounds 26b and 29b effectively inhibit LSD1 with the IC
Identifiants
pubmed: 33775841
pii: S0960-894X(21)00219-5
doi: 10.1016/j.bmcl.2021.127993
pii:
doi:
Substances chimiques
Enzyme Inhibitors
0
Tranylcypromine
3E3V44J4Z9
Histone Demethylases
EC 1.14.11.-
KDM1A protein, human
EC 1.5.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
127993Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.